Endovasc Inc., Pyramid Laboratories deal

Pyramid will manufacture clinical batches of EVSC's Liprostin alprostadil to treat intermittent claudication due to peripheral arterial disease (PAD). EVSC expects to start a Phase IIIa trial of the ...